Subscribe

Snapshot

DOI:

Focused and accessible - a renewed EuroIntervention!

We hope your year has begun well and full of excitement! It certainly has for us at EuroIntervention where we’re still at the beginning of all the new graphic changes and scheduling we spoke about in the last issue. And here it is – the first of our new, leaner, and more timely Journals that you will be receiving every 2 weeks. What do you think? We’re interested in your reactions and comments, so don’t hesitate to contact us online.

And, as for this issue itself, here are the key topics you’ll find right now:

EuroIntervention state-of-the-art

In a state-of-the-art on coronary spasm and vasomotor dysfunction, Zachary S. Yaker, Claire E. Raphael and colleagues review the current understanding, pathophysiology and treatment approaches for this frequently underdiagnosed condition.

Transcatheter aortic valve replacement explant for failed balloon-expandable valves vs failed self-expanding valves

Is mortality in transcatheter aortic valve replacement (TAVR) explantation associated with the type of failed transcatheter heart valve? Syed Zaid, Gilbert H.L. Tang and colleagues compare the outcomes of balloon-expandable valves versus self-expanding valves TAVR explantation using the EXPLANT-TAVR registry. The authors evaluate endocarditis, paravalvular leakage, structural valve deterioration and patient-prosthesis mismatch as well as mortality associated with the explantation of each valve type.

Prolonged mechanical circulatory support in high-risk PCI

What happens when you put high-risk PCI patients on prolonged mechanical circulatory support? Sugi Min, Jeffrey W. Moses and colleagues discuss early recognition of high-risk PCI and how best to wean patients off mechanical circulatory support, including the use of right heart catheterisation.

Real-world management of aortic stenosis patients

In a unique study out of Denmark, Xi Wang, Ole De Backer and colleagues examine the confluence of guideline recommendations and Heart Team evaluations. Focusing on a region with nearly 3 million people where all aortic stenosis patients are channelled through one centre, the authors analyse the value of the Heart Team in this “real-world” practice setting.

Volume 20 Number 2
Jan 15, 2024
Volume 20 Number 2
View full issue

Suggested by Cory

Editorial

10.4244/EIJ-E-25-00022 Sep 15, 2025
An ongoing quest to discern the optimal antithrombotic therapy after TAVI
Hayashida K and Iwata J
free

Translational research

10.4244/EIJ-D-24-01000 Sep 15, 2025
DurAVR – a novel biomimetic balloon-expandable transcatheter valve for TAVI, valve-in-valve TAVI and redo-TAVI
Meier D et al
open access

Research Correspondence

10.4244/EIJ-D-25-00255 Sep 15, 2025
Redo-TAVI with the ACURATE platform for failure of short-frame transcatheter heart valves
Tarantini G et al

Original Research

10.4244/EIJ-D-24-01066 Sep 15, 2025
VARC-HBR criteria validation in TAVI patients on oral anticoagulation
Overduin D et al

Editorial

10.4244/EIJ-E-25-00038 Sep 15, 2025
Evolving cutoff values for optimising left main stenting with intravascular imaging
de la Torre Hernandez J
free

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free

Flashlight

10.4244/EIJ-D-25-00121 Sep 15, 2025
Calcium mapping by 3DStent technology
Amabile N and Benamer H
Trending articles
56.1

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
56.1

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
47.3

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free
28.25

Clinical research

10.4244/EIJ-D-19-01006 Aug 7, 2020
Coronary collaterals and myocardial viability in patients with chronic total occlusions
Schumacher S et al
free
Chat with Cory
Hello , I'm Cory and I will do my best to answer your questions about this article. Please remember that this is an experimental feature, and that I'm still learning.
Can you provide a summary of the key findings in this article?
Can you extract and explain the primary hypothesis or research question addressed in this article?
What are the potential clinical applications or implications of the results presented in this paper?
How does this research contribute to our current understanding of cardiovascular disease management?
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved